Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Lipid profiles are associated with lesion formation over 24 months in interferon-β treated patients following the first demyelinating event.

Weinstock-Guttman B, Zivadinov R, Horakova D, Havrdova E, Qu J, Shyh G, Lakota E, O'Connor K, Badgett D, Tamaño-Blanco M, Tyblova M, Hussein S, Bergsland N, Willis L, Krasensky J, Vaneckova M, Seidl Z, Ramanathan M.

J Neurol Neurosurg Psychiatry. 2013 Nov;84(11):1186-91. doi: 10.1136/jnnp-2012-304740. Epub 2013 Apr 17.

PMID:
23595944
2.

Intramuscular interferon-beta-1a: in patients at high risk of developing clinically definite multiple sclerosis.

Siddiqui MA, Wellington K.

CNS Drugs. 2005;19(1):55-61; discussion 63-4. Review.

PMID:
15651905
3.

The importance of early diagnosis of multiple sclerosis.

Miller JR.

J Manag Care Pharm. 2004 Jun;10(3 Suppl B):S4-11. Review.

PMID:
15253684
4.

[Are there arguments for initiating an etiological treatment at the onset of the first demyelinating episode?].

Vermersch P.

Presse Med. 2004 Feb 14;33(3):180-6; discussion 192. Review. French.

PMID:
15029033
5.

[Interferons and neurologic diseases].

Vermersch P, de Seze J, Ferriby D, Stojkovic T.

Rev Med Interne. 2002 Nov;23 Suppl 4:475s-480s. Review. French.

PMID:
12481402
6.

Impact of delayed diagnosis and treatment in clinically isolated syndrome and multiple sclerosis.

Kennedy P.

J Neurosci Nurs. 2013 Dec;45(6 Suppl 1):S3-13. doi: 10.1097/JNN.0000000000000021. Review.

PMID:
24217189
7.

Assessing treatment response to interferon-β: is there a role for MRI?

Dobson R, Rudick RA, Turner B, Schmierer K, Giovannoni G.

Neurology. 2014 Jan 21;82(3):248-54. doi: 10.1212/WNL.0000000000000036. Epub 2013 Dec 11. Review.

8.

[Clinically isolated syndrome].

Platten M, Lanz T, Bendszus M, Diem R.

Nervenarzt. 2013 Oct;84(10):1247-59. doi: 10.1007/s00115-013-3845-1. Review. German.

PMID:
24081277
9.

Cholesterol and markers of cholesterol turnover in multiple sclerosis: relationship with disease outcomes.

Zhornitsky S, McKay KA, Metz LM, Teunissen CE, Rangachari M.

Mult Scler Relat Disord. 2016 Jan;5:53-65. doi: 10.1016/j.msard.2015.10.005. Epub 2015 Oct 19. Review.

PMID:
26856944
10.

[Can multiple sclerosis be diagnosed on a first demyelinating event?].

de Seze J.

Presse Med. 2004 Feb 14;33(3):174-9; discussion 192. Review. French.

PMID:
15029032

Supplemental Content

Support Center